Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7729427

Concept 2017-10-01 to
2017-12-31
As at
2017-12-31
2017-04-01 to
2017-12-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-12-31
2016-10-01 to
2016-12-31
2016-04-01 to
2016-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
35,454,000,000 JPY
46,782,000,000 JPY
36,202,000,000 JPY
Ordinary profit (loss)
809,000,000 JPY
642,000,000 JPY
780,000,000 JPY
Profit (loss)
943,000,000 JPY
861,000,000 JPY
961,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
32,701,000,000 JPY
32,545,000,000 JPY
32,639,000,000 JPY
Total assets
71,030,000,000 JPY
68,788,000,000 JPY
71,265,000,000 JPY
Dividend paid per share
40.00
44.00
4.00
Basic earnings (loss) per share
77.24
106.37
95.86
62.11
106.88
Diluted earnings per share
Equity-to-asset ratio
0.460 xbrli:pure
0.473 xbrli:pure
0.458 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.